uploads///Chart  Med Dev

Johnson & Johnson’s Medical Devices Segment: 4Q17 Estimates

By

Jan. 22 2018, Updated 9:02 a.m. ET

Medical Devices segment

Johnson & Johnson’s (JNJ) Medical Devices segment includes products for specialty surgery, orthopedics, cardiovascular care, surgical care, diabetes care, and vision care.

The above chart compares revenues for the Medical Devices segment over the last eight quarters.

Article continues below advertisement

Medical Devices brands

The Medical Devices segment includes the following brands:

  • Animas Corporation: diabetes products
  • Biosense Webster: advanced cardiac diagnostic, therapeutic, and mapping tools
  • DePuy Synthes: orthopedic and neurological products
  • Ethicon: surgical technologies and solutions, including sutures, staplers, trocars, and hemostats
  • Janssen Diagnostics: diagnostic and health IT (information technology) solutions
  • JNJ Vision Care: disposable contact lenses and eye care products
  • LifeScan: OneTouch brand of blood glucose monitoring systems
  • Mentor: global aesthetics products, including breast implants and facial aesthetics

Let’s look at the expectations for each of these franchise in the Medical Devices segment for 4Q17.

Cardiovascular care

Cardiovascular care is expected to report growth in revenues in 4Q17 due to the increase in sales of electrophysiology products, including the ThermoCool SmartTouch contact force sensing catheter.

Article continues below advertisement

Diabetes care

Diabetes care is expected to report a decline in revenues for 4Q17 due to pricing pressure and competition in self-monitoring blood glucose devices.

Orthopedics

The orthopedics franchise is expected to report growth in revenues for 4Q17 following the growth in hip and trauma products, partially offset by lower sales in knee and spine products.

Article continues below advertisement

Surgery

The surgery franchise is expected to report growth in revenues for 4Q17 following strong sales of general surgery products and advanced surgery products, partially offset by lower sales of specialty surgery products.

Vision care

The vision care franchise is expected to report growth in revenues for 4Q17 due to strong sales of contact lenses and the inclusion of Abbott Medical Optics.

The Health Care Select Sector SPDR ETF (XLV) holds 11.8% of its total investments in Johnson & Johnson (JNJ), 4% in Amgen (AMGN), 6.5% in Pfizer (PFE), and 5.1% in Merck & Co. (MRK).

Advertisement

More From Market Realist

  • CONNECT with Market Realist
  • Link to Facebook
  • Link to Twitter
  • Link to Instagram
  • Link to Email Subscribe
Market Realist Logo
Do Not Sell My Personal Information

© Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.